Health Care & Life Sciences » Biotechnology | Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.96
Market Cap
$163.85 M
Shares Outstanding
27.49 M
Public Float
23.66 M

Profile

Address
131 Hartwell Avenue
Lexington Massachusetts 02421
United States
Employees -
Website http://www.aldeyra.com
Updated 07/08/2019
Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A.

Financials

View All

Richard H. Douglas
Chairman
Todd C. Brady
President, Chief Executive Officer & Director